← Back to All Filings

Procter & Gamble Health Care CEO Paul Gama Sells $477.5K in Common Stock

Low SignificanceNovember 3, 2026 at 10:36:43 AM EST

PROCTER & GAMBLE Co

$PG4CIK: 0000080424

Subscribe to track PG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# Insider Transaction: Procter & Gamble Co ($PG)
**Insider**: Paul Gama (CEO- Health Care)
**Transaction**: Sale (Code: S)
**Date**: 2026-10-30
**Shares Transacted**: 2,894 @ $165.00
**Total Value**: $477,510.00
**Shares Remaining**: 43,898.88 Direct (plus 1,183.97 Indirect)
**Significance**: Low (Modest reduction of total holdings, ~6.2% sold)

Comprehensive Analysis

Executive Summary

On October 30, 2026, Paul Gama, CEO of Health Care at Procter & Gamble Co ($PG), executed an open-market sale of 2,894 shares of Common Stock at an average price of $165.00 per share, generating gross proceeds of $477,510.00.

Transaction Details

  • Security: Common Stock
  • Transaction Code: S (Open market or private sale)
  • Volume: 2,894 shares
  • Execution Price: $165.00
  • Total Consideration: $477,510.00
  • Rule 10b5-1 Plan Indicator: 0 (Transaction was not reported under a Rule 10b5-1 trading arrangement)

Holdings Analysis

Following this disposition:

  • Direct Ownership: 43,898.8803 shares
  • Indirect Ownership: 1,183.969 shares held through a Retirement Plan Trustee
  • Total Retained Position: 45,082.8493 shares

The transaction represents a sale of approximately 6.2% of the insider's directly held equity position, indicating substantial continued alignment with the company.

Market Impact & Significance

This transaction is categorized as Low significance due to the relatively modest dollar amount compared to the overall market capitalization of Procter & Gamble, as well as the insider retaining over 93% of their equity stake.

Topics:#PG#ProcterAndGamble#InsiderSelling#StockMarket#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.